The use of acidic MPAs (pH 2–4) is the default in pharmaceutical testing because they suppress silanol ionization (from Si-OH to Si-O -) and improve peak shape for basic drugs. However, highly ...
Forma Life Sciences, Inc. today announced its launch as an independent, operator-owned contract development and manufacturing ...
BETHLEHEM, Pa., June 22, 2011 /PRNewswire/ -- In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I ...
Pharmacology and pharmaceutical sciences encompass the integrated study of how chemical agents interact with biological systems to produce therapeutic and adverse effects, and the design and ...
Patient-centric drug development enhances adherence and treatment outcomes by incorporating patient input into the process, supported by FDA guidance. CDMOs have become strategic partners, offering ...
WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and ...
As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...
Award-winning Agility Life Sciences brings a proven track record in drug formulation for a number of pharmaceutical and biotechnology clients. Conduit has developed a series of novel, advantageous ...
This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of outsourcing, emerging technologies, manufacturing advancements and industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results